card-3216_Biochemistry expert scientific with eyeglasses
Digital innovation

Driving operational improvements and quality of our services

card-3210_Laboratory technicians conduct a series of tests on a chemical analyzer
Science Innovation

Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas

card-3242_Scientist using tablet while colleagues working behind
Download our Corporate brochure

We are IQVIA Laboratories, a leading clinical trial laboratory services organization with end-to-end laboratory services and secure, enterprise-wide biospecimen and consent management solutions.

Download
card-3233_Laboratory scientist working at lab with micropipette, and 96 well plate
Corporate Video

Our commitment to customer success is embedded in every facet of our operations.

card-3210_Laboratory technicians conduct a series of tests on a chemical analyzer
Science Innovation

Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas

card-3216_Biochemistry expert scientific with eyeglasses
Digital Innovation

Driving operational improvements and quality of our services

English You are about to exit for another IQVIA country or region specific website Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. Ok Open in new tab Search
Press Release

Q² Solutions Expands Vaccines Business Development Coverage in Europe

Q² Solutions announces the addition of business development resources in support of their vaccine clinical trial laboratory services in EMEA

By Default Author


Morrisville, N.C. – February 12, 2020 – Q2 Solutions, a leading clinical trial laboratory services organization, is pleased to announce the addition of business development resources in support of their vaccine clinical trial laboratory services in the Europe, Middle East, and Africa (EMEA) region. 

Q2 Solutions welcomes Joanna Zmurko, Senior Executive, Customer Solutions, who will be covering the EMEA region for their vaccine services. Joanna joins Q2 Solutions from Merck KGaA where she served as an R&D Virology Scientist as well as an Account Manager. Prior to Merck KGaA, Joanna was a Marie Curie Research Fellow at Katholieke Universiteit Leuven in Belgium, focusing on flaviviruses such as dengue and Zika. 

“We are very excited to have a colleague with Joanna’s depth of skill and knowledge join our team. She is a pivotal addition to our team as we drive our global strategy forward, specifically focusing on expanding our penetration in the EMEA market”, said Kevin Jones, Q2 Solutions General Manager, Bioanalytical/ADME and Vaccines Laboratories. "Vaccine development is a key area of growth in the industry today and this addition of business development coverage aligns with our Vaccine growth strategy, as we further evolve and invest to service our customers and their needs across the globe.”

Visit www.q2labsolutions.com/vaccines to learn more about Q2 Solutions clinical trial vaccine laboratory services.


About Q2 Solutions
Q2 Solutions is a leading clinical trial laboratory services organization with end-to-end laboratory services and secure, enterprise-wide biospecimen and consent management solutions. With a relentless focus on quality and innovation, Q2 Solutions uses its global experience and scientific expertise to transform science and data into actionable medical insights that help customers improve human health. A joint venture of IQVIA (formerly QuintilesIMS) and Quest Diagnostics, Q2 Solutions combines the best of each parent organization’s clinical trials laboratory services capabilities to fulfill its mission of treating each sample as if a life depends on it. To learn more, visit www.q2labsolutions.com.

By Default Author